Reddit Posts
Why is ABCL up so much today?
Little less than 3 months in and I think I’m doing well
ABCL Before May 11 Earnings: The AI Antibody Discovery Bag Is Finally Entering Catalyst Season - DD
AbCellera Biologics ( $ABCL ) — Deep Dive On Platform, Pipeline, Cash, Insiders, Institutions, And The Road Ahead
ABCL: AI-Driven Drug Discovery Under $5 - Value Trap or Deep-Tech Opportunity?
YOLO: 8,000 shares of $ABCL 🚀 you still got time!
Any metalheads wanna learn the stock market together?
YOLO $ABCL: Earnings Beat, AI Discovery, Phase 2 Loading!
One AI defense contractor is quietly securing huge government deals
$ABCL - pretty perfect breakout backtest. Now moving higher. This one could go much higher still. $10-$15
AbCellera Tops Q2 with Strong Revenue and Pipeline Gains—Is a Federal mRNA Funding Shift the Next Catalyst?
5 UNDER-$6 BIOTECH MISSILES LOCKED AND LOADED
5 UNDER $6 BIOBREAKOUTS YOU CAN’T IGNORE
$ABCL – They Just Put a $17 Target on It. Earnings Are Next.
Why ABCL is my highest conviction position
🧬 Comprehensive DD on AbCellera (ABCL): From 2012 to 2025 – Full Analysis & Insights
🧬 Comprehensive DD on AbCellera (ABCL): From 2012 to 2025 – Full Analysis & Insights
📊 Quick Analysis of $ABCL – Are We Facing a Squeeze?
📊 Quick Analysis of $ABCL – Are We Facing a Squeeze?
📊 Quick Analysis of $ABCL – Are We Facing a Squeeze?
AbbVie drops $700M upfront on IGM… but no one’s talking about their MEGA partnership with AbCellera ($ABCL)
🧬 $ABCL – From $2 to 52W Highs… and it’s just getting started. Next stop: $6 – then $10?
AbCellera (ABCL): The Sleeper AI Antibody Factory – DD
AbCellera Biologics (ABCL) Stands Out in Active Option Classe
Will $ABCL Keep Climbing After Yesterday’s Surge — Clinical Trial Momentum or something else?
$SLDP – The Most Slept-On Solid-State Battery Play in the Market Right Now
$ABCL – Once in a Decade Opportunity with a Potential Short Squeeze
$ABCL – Once in a Decade Opportunity with a Potential Short Squeeze
$ABCL is the most underrated biotech in the market. Here’s why I’m all in
RAMP,SIMO,PRCT,KYMR,SDGR,HSAI,ABCL,AAPL,UPST,SE.these 10 stocks represent a diverse range of industries and have the potential to double your investment in 2023. these companies demonstrate strong financials, positive growth trends, and favorable analyst ratings
AbCellera (ABCL): The AI-Powered Drug Discovery Gem You've Been Snoozing On - An Easy 2x Play - DD
Anyone with some news/explanation for Abcellera (ABCL) movement past two days?
After Hours Gainers $AXON +5.9% $CELH +4.3% $ELY +4.3% $ABCL +4.1% $BOOT +2.7% $SOFI +2.3% $FSR +1.5% $GTLB +1.4% $SQM +1.2% $Z +1.2%
I smell blood in the water - exploiting potential $FB Related margin calls
I smell blood in the water- exploiting potential $FB related margin calls
$ABCL: Is AbCellera a buy at it’s current price?
I’ve Had an Epiphany (Or am I retarted? You tell me)
Is it time to switch from growth to value investing?
UPDATED: Why $ABCL Is a Multi Bagger in This Cangaroo Covid/Omicron/Inflation Market.
$ABCL - A Long Term Winning Gem Inside a Crowd of Some Dodgy Covid/Omicron Plays. Here is How About How Landed on It
Peter’s ABCL will take me to the 🌚 and beyond
Pumpin’ ABCL - I believe in you, Peter
What are you ADDING on to this week?
$ABCL to provide COVID treatment to EU and back at IPO pricing with more treatments in the works
Noticing the $ABCL push during extended hours, this daily has a good range reclaiming the 20 and 50 SMA in the daily.
Does anyone use butterfly's during long LEAPS plays on slow movers?
ABCL- a call option on all future antibody drugs at their IPO price
Is ABCL Having Another Rally Soon Where It Shoots Up 30-40%?
ABCL DD - generational like company at a cheap price
$ABCL - Chance to buy in at IPO price
Daily short sale volume percent for stock ticker ABCL is 72% on Jun 08, 2021
$ABCL got hit with analyst downgrades, watch out for upcoming dips from this news
ABCL Abcellera will double this week. Up 30% today.
$ABCL Reports 1,908% Increase in Revenue (YOY) ; Peter Thiel, A Board of Director!
$ABCL Reports 1,908% Increase in Revenue (YOY) ; Peter Thiel, A Board of Director!
ABCL AbCellera Short interest at 24%, a Peter Thiel company, can someone confirm to squeeze the shorties?
Mentions
In all seriousness, I think ABCL is one of these stocks, but it’s a long term play
Buy $40 of ABCL don’t look at it and come back in 5 years.
Yeah, a decent chance biotech is the next phase of the AI play. I’ve got some nice positions in peptides/antibodies (ABCL/ABSI) and gene therapies (CRSP/BEAM/PRME). Also RXRX as a pure AI biotech play
Biotech: ABCL, ABSI, GENB, RXRX
This looks like legitimate biotech DD rather than a scam concern. ABCL is a real company with a genuinely interesting antibody discovery platform. The hantavirus angle is interesting if they're partnering on an outbreak response - that kind of government/emergency health work can accelerate timelines significantly. Key questions: is this a signed contract or an MoU, what's the total contract value, and does it materially change their revenue trajectory? Biotech catalyst plays require close reading of the actual contract terms.
ABCL is my next act. RKLB was my first masterpiece.
Hantavirus Tracker: https://www.arcgis.com/apps/dashboards/5c68442d2afc42d7ba2696e4cd393729 Hantavirus biotechnology names: $MRNA $54.35 $INO $1.46 $TRAW $2.18 $EBS $9.50 $NVAX $10.11 $SABS $4.11 $ABCL $5.24
Hantavirus related stocks and the closing prices as of May 8th: $MRNA $54.35 $ABCL $5.24 $NVAX $10.11 $INO $1.46 $TRAW $2.18 $EBS $9.50 $SABS $4.11 Hantavirus Tracker: https://www.arcgis.com/apps/dashboards/5c68442d2afc42d7ba2696e4cd393729
Hantavirus Tracker: https://www.arcgis.com/apps/dashboards/5c68442d2afc42d7ba2696e4cd393729 Hantavirus related stocks and the closing prices as of May 8th: $MRNA $54.35 $ABCL $5.24 $NVAX $10.11 $INO $1.46 $TRAW $2.18 $EBS $9.50 $SABS $4.11 Missing any important names?
Hantavirus will not lead to an epidemic. It's been around for ages. I did get into ABCL though mostly for the shortsqueeze potential. HIMS at \~$25 is just a good long-term play in general (5 year support)
#TLDR --- Ticker: ABCL Direction: Up Prognosis: Buy/Hold Shares (OP is holding 8,000 shares at $4.25) Catalyst: May 11 Phase 1 Data Readout (ABCL635) Face-Melting Risk: High ("Biotech can vaporize your face") Summary: AbCellera is shedding its "post-COVID SPAC corpse" reputation and transitioning into a clinical-stage biotech with a massive $700M cash runway. The May 11 earnings call is less about the financials and all about the interim Phase 1 data for their lead program (ABCL635 for hot flashes). This is the first real test to see if their AI antibody discovery machine can actually produce viable drugs.
ABCL. They have a molecule in clinical trial that would be the first non-hormonal drug for menopausal hot flashes. They have lots of other things in the works but this is the shortest term potential that could be huge. Phase 2 readout is later this year.
IONQ, ABCL y IBRX... ah, y retomando HIMS
Consider PLUG. It’s close to your price range. Another one with potential is ABCL.
I bought some NVidia back when it split and again last year in april when the market freaked out over trumps bs. Just been holding those since. ABCL is one i've been putting money into
AMZN - mainly because of their focus/investment in Robotics GOOG - youtube, AI, is undervalued right now UBER - innovative AUR - almost a leader in autonomous driving (future of trucking) BULL - massive upside, sitting on tons of cash and growing SMCI - i dont really believe in it and I think margin is a problem with them but they have significant upside. Undervalued right now RXRX - innovative, could be big in future ABCL - same reasons Hyundai HYMTF - they own boston dynamics - not easy to invest in this if youre in North America
VXRT. Risk reward here, the price is beat down, trading off exchange but has potential to go big if their vaccine tech gets to market or bought up. ABCL is if their AI drug discovery proves out will be a royalty/revenue generator but its still early. They have a healthy cash runway. Its a buy and hold for growth in the future.
I've been in $ABCL (AbCellera) for awhile now. Interesting biotech company using, for lack of better terms, a sort of AI to help them accelerate finding new treatments and drugs. Peter Thiel was an early investor, probably before they went public. I think he sold a chunk of what he had, though. It's currently around $3. Its lows are just under $2. Insiders have been buying more shares when we get to lows like that. They've had some on and off again contracts with some bigger drug companies that worked out pretty well. Pretty quiet at the moment, though. I do know they have a drug going through trials right now. 5-10 years from now, it has the potential to really go crazy at some point, I just don't know when. So, I keep chucking a little bit at it here and there. Its IPO was in 2021, so, the insiders/private equity that wanted to get out I think have done so by this point. The long term chart has the appearance of having found its ultimate lows. We may be setting a higher low from the most recent bottom now. It did go above $6 last fall. Seems to be the range for the time being, $2 to $6. Might continue to bounce around this range for a couple more years for all I know, but I do think eventually it runs hard. Outstanding shares is just under 300 million last I checked. So, not exactly a low float stock capable of truly wild stuff, but still small enough that if they get something that provides for great, continued revenue growth, it can still run quite a bit. Smaller OS than $MRNA, which eventually found itself in the $400 range in 2021... Just shy of $50 right now.
I tend to look more at smaller / less crowded names rather than the obvious mega caps. A few I own (higher risk, obviously): LFMD – Telehealth / men’s health. I like the direct-to-consumer model and the margin expansion story if they keep scaling efficiently. Not saying it’s risk-free, but if they execute, it can re-rate. ABCL – AI-driven antibody discovery. This one is more of an asymmetric bet for me. If their platform consistently produces viable drug candidates and partnerships convert, upside could be significant. Still very biotech-risk heavy. GAMB – Gambling.com Group. Asset-light affiliate model in online betting. Solid cash generation and operating leverage if the U.S. market continues expanding state by state. CRMD – Small-cap biotech with a commercial product (DefenCath). This is more of a “commercial ramp” thesis. If adoption grows steadily, it could surprise people. If not, it’s dead money. All of these are volatile and definitely not “sleep well at night” positions — but that’s kind of the tradeoff for looking outside the usual Google/Amazon names. Just my approach.
Yup, I've started going into gene therapy (e.g., CRSP, BEAM) and antibody/peptide design companies (e.g., ABSI, ABCL, GMAB) myself
dude did you sell ABCL?
OPTT, hoping it goes on sale tomorrow so I can jump back in. I did well with GSAT, in at $1.83 pre reverse split. ABCL has done well for me, they have a nice cash runway and they are in a phase 2 drug trial. Price is down right now, I’ll add some shares if it falls a bit more.
When I’m losing conviction it’s either time to get out or rethink strategy if it’s still correct and if so push through. That’s why I am relocating some of my capital to biotech: $IBRX, $TMDX, $ABCL and $OPEN. Each a unique moat: from solving cancer without chemo, Tesla algorithm applied to organ transplant market, palentir for biotech and a market-maker/insurance company for the housing market run by one of the best upcoming CEOs in the world. You can find it on my X @BigShort24
ABCL will pop this year when their trial results are in in summer
Yessir! Really carried my portfolio last year. There is still a lot of potential upside if they get a nasdaq listing. Im excited for what the future holds. Also, I think ABCL will have a good year.
Thankful to get out of ABCL with some profits. Since I sold it’s gone down below my entry price. I just had a feeling. I will never invest in biotech or pharma
Wonder why ABCL was up today then
My focus is on long-term investment, so my core position is the FTSE All-World (VWCE). The rest is therefore more risky conviction picks as a potential boost for the next 5-10 years: KRKNF, RKLB, ASTS, ONDS, NBIS, IREN, LAES, ABCL, PRME
Context matters. Do you have $20-25 because you're dirt poor/low earnings and that's all you can save up? Or do you view the $20-25 as FU money and you've got enough saved aside as emergency funds to save yourself if needed? If it's the former, just VT and forget about it. If it's the latter, go ahead and buy some that fall between moonshots and and stable growth (Don't buy dumb shit like KULR, IPST, BYND. Consider stuff like POET, ABCL, RKLB, ASTS when they were pennies.)
AI medicine, because they are going to run out of hyped up stocks: RXRX ABCL SDGR ABSI
VRCA, CAPR, VIR, LUNG... maybe ABCL, VTYX
My current portfolio, M37. RR - 83% (pre covid buy, slowly reducing) VWRA - 11% (increasing) IAG - 1.5% (hold, small dividend growing) QQQI - 1.3% (drip) SPYI - 1.3% (drip) ABCL - 0.5% (speculative buy, hold) BTCI - 0.4% (drip) KSPI - 0.4% (speculative buy, hold)
|Category|Winner|Insight| |:-|:-|:-| |Business Model|**ABCL**|Capital-light, partner-centric| |Data/Tech Moat|**RXRX**|Hardest-to-replicate dataset| |Revenue Visibility|**ABCL**|Milestones + royalties| |Long-term Upside|**RXRX**|If platform works → giant outcome| |Risk Level|**RXRX (high)**|Most speculative| |Financial Strength|**ABCL**|More runway, less burn|
ABCL, IOVA, MRNA. AI is imploding; get into BIO y’all.
No, leverage doesn’t cost some of the initial investment. They may have an Expense Ratio. But it should not be a lot. You need to research a bit about how leveraged stocks/ETF behave. There is something called as “time decay” Imagine you have a stock of ABC company at 100$ today. And a 2X leveraged of that same stock. Let’s call it ABCL and is also trading at 100$ Let’s say ABC stock goes down 40% today. ABC is now trading at 60$ But, ABCL will go down 80%. ABCL will now trade at 20$. Next day, imagine: ABC stock goes up 66%. Which means ABCL will go up 132% (2X) Now, ABC is 60$ * 1.66 (66%) =$99.60 (back to original price) But, ABCL is 20$ * 2.32 (132%) = $46.40 ABC is back to 100$ ABCL is still at 46.40$ This is how leveraged stocks work. You can lose a lot if the stock goes down and up a lot.
yeah, i run similar, my 401 goes to the fidelity version of spy and the ira/roth are mainly voo/vgt with a newer NATO etf i've been buying and then various stocks like RKLB, LTBR, ABCL, NVIDIA and the sort that I've picked up along the way
Good take. $ABCL has real fundamentals. I’ve been using tickr-bio to track biotech events lately, it’s actually pretty useful for stuff like this.
Good take. $ABCL has real fundamentals. I’ve been using TICKR-BIO to track biotech catalysts lately, it’s actually pretty useful for stuff like this.
I did this a couple months or so ago on ABCL, got $5 calls out to January. Wish I remembered what the company does
Thoughts on RKT & ABCL ? ABCL fluctuates like a patient on bipolar medication RKT pissing all over my portfolio
Reminds me a lot of ABCL which hit a 52 week high last week
Been doing well off HOVR, GEVO, ABCL
Shout out to OP for earlier contributions. Comparing **IRWD vs ABCL** risk/reward (used LLM as well). What am I overlooking in ABCL? # IRWD – Upside Case * **Close**: $1.43 * **Fair value**: \~$2.10 (DCF on royalty stream) → **\~47% upside** * **Q2 Highlights**: * LINZESS rev $85.7M, adj. EBITDA $50.1M, net income $23.6M * Cash $93M vs. \~$199M notes due 2026 * 2025 guide: rev $260–290M, EBITDA >$105M * **Valuation**: \~$120M FCF/yr, discounted over 6 yrs → \~$2.10/sh equity “floor” * **Risks**: optimistic FCF conversion, royalty erosion, working capital drag, unmodeled liabilities # ABCL – Snapshot * Rev $17.1M, R&D $39M, net loss –$34.7M * Liquidity \~$753M (cash + funding) * No stable cash flow; valuation tied to pipeline progress & clinical milestones **Contrast**: IRWD = royalty “floor” undervalued \~47% upside; ABCL = strong cash but pure pipeline risk.
Any thoughts in here on ABCL or RUM?
I’ve had this on a watchlist for 4 months. No news and 3x volume today… Unless someone has the scoop, I’m wondering if it’s being pulled up by the PFE jet stream. a lot of bio tech and healthcare seemed to move over the last 48 hours on the Pfizer news. $NTLA, $ABCL, $NUVB (yesterday), $MRNA, $NVAX, $MERCK… all up.
sometimes you just have to buy a stock and let it sit, ABCL is one of the few stocks in the green today and i wasn’t expecting it
No. I just gave it a shot. Like ABCL.
ABCL out of penny stock land 🥹 so proud
$ABCL $GRAB open your eyes mates!<3
ATCH is this subs current darling, it’s done well but the minute it tanks everyone here will be acting like they all knew it was coming. Pump and dumps are fine if you know and can handle the risks but if you want real possible penny stocks investments I’ve got a few im watching. - HGRAF (I am balls deep on this one. Pre revenue highly speculative graphene company. Tons of risk as there always is with penny stocks but it could be one of those life changing stocks that you can get into before it blows up to unbelievable levels. - RR Robotics company with massive upside - PNG, Kraken Robotics. Fun little Canadian company that won’t be little for long. Defence and had close ties and contracts to Anduril which is a giant. - ABCL. A long term bio company that could be huge. People claim it is the palantir of biotech because of how they leverage AI to make money on finding antibodies for other companies. Also developing two of their own drugs. Royalties will be the big money maker but this is a very long term hold as in 3-5 years +
ABCL up almost 10% today but I can’t find out why
What do people here think about SLDP, RUM & ABCL ?
In this for the long run OVID ABCL and SLS if anyone wants to hop on never say nobody didn’t warn yall ahead of time
$ABCL and $MBOT are the plays for this bulltember
Okay, here’s the math: ABC starts at $100. ABC drops to 40% to $60. ABC then grows 66.7% to get back to $100. ABCL, leveraged at .75x, starts at $100. ABCL drops 30% to $70. ABCL then grows 50% to $105. ABCL shrinks and then grows at 75% of ABC, and ends up at $105, while ABC is at $100. As others have pointed out, this is relatively easy to do on your own, so it doesn’t make sense to have an expensive ETF do it. But the math is right
You did the math wrong in your first example. ABC goes up 4%, but only goes down 3.85% to get back to 100. ABCL goes up to $103, then back down to $100.03. ABCL ends up ahead
No. You will get superior returns investing only $75 in ABC and $25 in a short term bond than $100 in ABCL. You also are not including the management fee.
Why would you pay $1 for only 75% of the benefit of stock growth? Just buy $75 of the stock instead of $100. $100 ABCL. Stock goes up 4%. Your ABCL goes to $103. Stock goes down 4%. Your ABCL goes down to $99.88. You lost 12 cents $75 ABC. Stock goes up 4%. ABC goes up to $78. Stock goes down 4%. ABC goes to $74.88. You lost 12 cents. Difference is you can invest the extra $25 into a short term bond and earned guaranteed income and beat ABCL returns
$ABCL Crazy: Short Interest: 39,805,894 shares Short Interest % Float: 19.63% Source: NASDAQ (short interest), Capital IQ (float) This combination, a sharp increase in short interest + no price drop, often creates very explosive moves if the stock moves upward
I chose $ABCL over ONDS and ChatGPT confirmed it was the better choice
$ABCL unique system for Ai drug discovery, patented tech, applications are endless. Palatir of Pharma.
I like SRPT and have a position in it. I think it's unfairly kept down, it may go up but it's probably going to be choppy. I don't know about ABCL, didn't do any research on that one. IMO short term potential VKTX >>> SRPT, SRPT doesn't really have short term catalysts coming.
As a bio quant, would you say VKTX is a better buy than ABCL or SRPT?
What do you guys think about ABCL earnings? Was it good or just indifferent? What will it do today? Up or down?
What do you guys think about ABCL after earnings? What will it do today? Up or down?
ABCL just crushed earnings
ABCL is printing me green tomorrow
$ABCL earnings just came out, -.12 actual vs. -.13 expected, currently up 17+% in AH
ABCL... https://preview.redd.it/k614jjg7snhf1.jpeg?width=115&format=pjpg&auto=webp&s=9aad0381a08001656049b984ac0cce4ca93684de
Bought some ABCL shares.... helmets on for ER. Good luck all if you are riding this pod.
I think ABCL is a long term diamond hand. I bought few shares when it was like 2$ish off of some dude's good dd on here. Can't find the link but you can search for it. It's CEO also has a good rappot. In short, I am adding and holding this for long. NFA.